| Real-World Effectiveness of Pegloticase Associated with Use of Concomitant Immunomodulatory Therapy JRCMDMSMPH Emily E. Holladay MPH, Amy S. Mudano MPH, Fenglong Xie PhD ... Arthritis Care & Research, 2024 | | 2024 |
| Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation EE Holladay, AS Mudano, F Xie, J Zhang, TR Mikuls, B LaMoreaux, ... Arthritis Research & Therapy 26 (1), 86, 2024 | | 2024 |
| The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare Y Liu, T Arora, J Zhang, SK Sodhi, F Xie, JR Curtis Bone 178, 116954, 2024 | | 2024 |
| Compliance with Romosozumab and Fracture Risk Among Postmenopausal Women in the U.S [abstract] ZJ Liu Y, Arora T, Curtis J Arthritis Rheumatol. 2023; 75 (suppl 9)., 2023 | | 2023 |
| Evaluation of Outcomes Following Discontinuation of Pegloticase Therapy [abstract]. CJ Holladay E, Mudano A, Xie F, Zhang J, Mikuls T, LaMoreaux B, Padnick-Silver L Arthritis Rheumatol. 2023; 75 (suppl 9)., 2023 | | 2023 |
